Skip to Main Content

Author Details

Stephen T Sonis
Brigham and Women's Hospital
1971
278
68
PMIDPaper TitleJournal TitlePublished Year
37874927Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles.Oncologist2024
37874927Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles.Oncologist2024
36732740Psoriasis and oral health in adult United States population: a cross-sectional study.BMC Oral Health2023
36444518Differential associations of rheumatoid arthritis and periodontitis or tooth loss: A cross-sectional study.J Clin Periodontol2023
37993500Monte Carlo based dosimetry of extraoral photobiomodulation for prevention of oral mucositis.Sci Rep2023
36656592Quantifying Costs Associated With Survival Among Patients With Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg2023
36646388PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy.Int J Radiat Oncol Biol Phys2023
36707490Identification of a SNP cluster associated with taxane-induced peripheral neuropathy risk in patients being treated for breast cancer using GWAS data derived from a large cooperative group trial.Support Care Cancer2023
36869162Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma.Support Care Cancer2023
36932830Radiotherapy-induced severe oral mucositis: pharmacotherapies in recent and current clinical trials.Expert Opin Investig Drugs2023
37365149Avasopasem for the treatment of radiotherapy-induced severe oral mucositis.Expert Opin Investig Drugs2023
36732740Psoriasis and oral health in adult United States population: a cross-sectional study.BMC Oral Health2023
37993500Monte Carlo based dosimetry of extraoral photobiomodulation for prevention of oral mucositis.Sci Rep2023
37365149Avasopasem for the treatment of radiotherapy-induced severe oral mucositis.Expert Opin Investig Drugs2023
36656592Quantifying Costs Associated With Survival Among Patients With Head and Neck Cancer.JAMA Otolaryngol Head Neck Surg2023
36444518Differential associations of rheumatoid arthritis and periodontitis or tooth loss: A cross-sectional study.J Clin Periodontol2023
36646388PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy.Int J Radiat Oncol Biol Phys2023
36869162Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma.Support Care Cancer2023
36932830Radiotherapy-induced severe oral mucositis: pharmacotherapies in recent and current clinical trials.Expert Opin Investig Drugs2023
36707490Identification of a SNP cluster associated with taxane-induced peripheral neuropathy risk in patients being treated for breast cancer using GWAS data derived from a large cooperative group trial.Support Care Cancer2023
34265157Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.Oral Dis2022
36110957Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.Front Oncol2022
35524296Oral lichen planus: comparative efficacy and treatment costs-a systematic review.BMC Oral Health2022
35900594A common infrastructure for real-world patient-reported symptoms: one size fits many.Support Care Cancer2022
35929562Using real world data to advance the provision of supportive cancer care: mucositis as a case study.Curr Opin Support Palliat Care2022
36060116Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider.Front Oral Health2022
36060117Precision medicine for risk prediction of oral complications of cancer therapy-The example of oral mucositis in patients receiving radiation therapy for cancers of the head and neck.Front Oral Health2022
35724774Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer.Int J Radiat Oncol Biol Phys2022
34265157Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.Oral Dis2022
34974194Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis.Tumour Virus Res2022
34714553The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies.CA Cancer J Clin2022
35724774Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer.Int J Radiat Oncol Biol Phys2022
35524296Oral lichen planus: comparative efficacy and treatment costs-a systematic review.BMC Oral Health2022
36110957Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.Front Oncol2022
35900594A common infrastructure for real-world patient-reported symptoms: one size fits many.Support Care Cancer2022
35929562Using real world data to advance the provision of supportive cancer care: mucositis as a case study.Curr Opin Support Palliat Care2022
36060116Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider.Front Oral Health2022
36060117Precision medicine for risk prediction of oral complications of cancer therapy-The example of oral mucositis in patients receiving radiation therapy for cancers of the head and neck.Front Oral Health2022
34974194Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis.Tumour Virus Res2022
34714553The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies.CA Cancer J Clin2022
33215315Industry and MASCC-an opportunity not to be missed.Support Care Cancer2021
33537946Network meta-analysis from a pairwise meta-analysis design: to assess the comparative effectiveness of oral care interventions in preventing ventilator-associated pneumonia in critically ill patients.Clin Oral Investig2021
33788003Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers.Support Care Cancer2021
33770116GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling.PLoS One2021
33716500Superoxide Dismutase as an Intervention for Radiation Therapy-Associated Toxicities: Review and Profile of Avasopasem Manganese as a Treatment Option for Radiation-Induced Mucositis.Drug Des Devel Ther2021
33555929Benefits of the Involvement of Dentists in Managing Oral Complications Among Patients With Oral Cavity and Oropharyngeal Cancer: An Analysis of Claims Data.JCO Oncol Pract2021
33712912A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment.Support Care Cancer2021
33595843Oral side effects of immune checkpoint inhibitor therapy (ICIT): An analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana-Farber Cancer Institute, 2011 to 2019.Cancer2021
33595722Treatment for Oral Mucositis-Current Options and an Update of Small Molecules Under Development.Curr Treat Options Oncol2021
33594509Exceptional toxicity resistance.Support Care Cancer2021
  • 1 - 50 of 556

Recommended Authors

Saskia Preissner
Charite-Universitatsmedizin Berlin
Career Start Year 2010
Number of shared co-authors 0
John Pang
University of Washington
Career Start Year 2009
Number of shared co-authors 1
Daniel R Clayburgh
Oregon Health & Science University
Career Start Year 2004
Number of shared co-authors 2
Akihiro Sakai
Tokai University
Career Start Year 2002
Number of shared co-authors 0
Kathrin Scheckenbach
Heinrich-Heine University
Career Start Year 2002
Number of shared co-authors 0
Hyunseok Kang
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 1
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Manoela Domingues Martins
Universidade Federal do Rio Grande do Sul
Career Start Year 1999
Number of shared co-authors 0
Sean M McBride
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Vinay K Jain
University of Texas M.D. Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 0
Jay O Boyle
Memorial Sloan Kettering Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 1
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 3
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 0
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 2
Wayne M Koch
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 3
Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Career Start Year 1987
Number of shared co-authors 5
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 3
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Paula K Roberson
and Clinical Center, Central Arkansas Veterans Healthcare System
Career Start Year 1984
Number of shared co-authors 0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
Charles L Loprinzi
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 0
Peter J Selby
College of Agriculture and Life Sciences, Cornell University
Career Start Year 1977
Number of shared co-authors 0
Adriana B??ez
University of Puerto Rico
Career Start Year 1977
Number of shared co-authors 0
Joseph A Califano
University of California
Career Start Year 1977
Number of shared co-authors 3
Scott M Lippman
Moores Cancer Center, university of california san diego
Career Start Year 1977
Number of shared co-authors 5
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Alessandro Villa
Co-authored papers 24
Joel B Epstein
Samuel Oschin Comprehensive Cancer Center
Co-authored papers 20
Linda S Elting
Co-authored papers 7
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 5
Thomas E Van Dyke
The Forsyth Institute
Co-authored papers 4
Marco F Ramoni
Children's Hospital Informatics Program, Harvard Medical School
Co-authored papers 3
Lucila Ohno-Machado
Escola de Administracao de Empresas - FGV, Stanford University, University of California San Diego, University of Sao Paulo, Yale School of Medicine
Co-authored papers 3
Winston Patrick Kuo
Harvard School of Dental Medicine
Co-authored papers 3
Lucila Ohno-Machado
Co-authored papers 3
David I Rosenthal
MD Anderson Cancer Center
Co-authored papers 3
Tor-Kristian Jenssen
Norwegian University of Science and Technology
Co-authored papers 3
Mark E Whipple
University of Washington School of Medicine
Co-authored papers 3
Peili Chen
University of Chicago
Co-authored papers 3
Mark W Lingen
University of Chicago Pritzker School of Medicine
Co-authored papers 2
Donna Neuberg
Co-authored papers 2
Charles W Scarantino
University of North Carolina
Co-authored papers 2
Coen R N Rasch
Leiden University Medical Center
Co-authored papers 2
Michael R Hamblin
Laser Research Centre, University of Johannesburg
Co-authored papers 2
Oreola Donini
Co-authored papers 2
Edward B Garon
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 2
Gil Alterovitz
Brigham and Women's Hospital
Co-authored papers 2
Hoang Nguyen
Co-authored papers 2
Sung Eun Choi
Co-authored papers 2
Michael Henke
Medical Center, University of Freiburg
Co-authored papers 1
Ravindra Uppaluri
Brigham and Women's Hospital
Co-authored papers 1
Peter J Park
Harvard Medical School
Co-authored papers 1
M Nicolson
Co-authored papers 1
Gustavo S Santos
University College London
Co-authored papers 1
T V Morgan
Co-authored papers 1
Randy Todd
Harvard/Massachusetts General Hospital
Co-authored papers 1
Release 1.2